Please try another search
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment. The company was founded in 2006 and is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Riva Kovjazin | - | - | Senior Scientist & Member of Scientific Advisory Board |
David Goren | - | - | CEO & Chairman |
Gadi Levin | 51 | 2016 | CFO & Director |
Shawn Langer | - | 2017 | Independent Director & Member of Scientific Advisory Board |
Ari S. Kellen | 61 | 2017 | Independent Director & Member of Scientific Advisory Board |
Michael Berelowitz | 80 | 2021 | Special Advisor to the Board |
Daniel N. Bloch | - | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review